Distinct improvement of pulmonary function, ground-glass opacity, hypoxia and physical findings in an idiopathic pulmonary fibrosis patient after pirfenidone treatment : a case report with a review of the literature-Reference-Cited by-同舟云学术

Distinct improvement of pulmonary function, ground-glass opacity, hypoxia and physical findings in an idiopathic pulmonary fibrosis patient after pirfenidone treatment : a case report with a review of the literature

Published:2020 Issue:3.4 Volume:67 Page:358-361
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Imakura Takeshi¹,Toyoda Yuko¹²,Sato Seidai¹,Koyama Kazuya¹,Nishimura Haruka¹,Kagawa Kozo¹,Takahashi Naoki¹,Naito Nobuhito¹,Murakami Kojin¹,Kawano Hiroshi¹,Azuma Masahiko¹³,Shinohara Tsutomu⁴,Nishioka Yasuhiko¹²

Affiliation:

1. Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

2. Department of Community Medicine for Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

3. Department of Medical Education, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

4. epartment of Community Medicine for Respirology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/67/3.4/67_358/_pdf

Reference15 articles.

1. 6. Dosanjh A : Pirfenidone : anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients. Eur J Pharmacol 536 : 219-222, 2006

2. 7. Okuda R, Hagiwara E, Endo T, Takemura T, Ogura T : A case of severe idiopathic pulmonary fibrosis effectively treated with pirfenidone. Jpn J Chest Dis 71 : 1144-1150, 2012

3. 8. Shintani Y, Endo D, Kumasawa F, Koyama D, Shikano S, Ishiwatari Y, Igei K, Okamoto N, Uematsu A, Morisawa T, Gon Y, Hashimoto S : Idiopathic pulmonary fibrosis well-controlled in progress good control for a long interval with pirfenidone : a case report. J Nihon Univ Med Ass 74 : 69-72, 2015

4. 9. Miyamoto A, Morokawa N, Takahashi Y, Ogawa K, Takeyasu M, Murase K, Hanada S, Uruga H, Mochizuki S, Takaya H, Kurosaki A, Kishi K : Marked improvement with pirfenidone in a patient with idiopathic pulmonary fibrosis. Intern Med 55 : 657-61, 2016

5. 10. Varone F, Mastrobattista A, Franchi P, Viglietta L, Poletti V, Tomassetti S, Dubini A, Tagliaboschi L, Calandriello L, Farchione A, Larici AR : Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis : improvement of clinical and radiological pattern after treatment with pirfenidone. Clin Respir J 12 : 347-351, 2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease;Inflammation and Regeneration;2024-07-19

2. Clinical features analysis and treatment of systemic lupus erythematosus related interstitial lung disease;International Journal of Rheumatic Diseases;2024-06

3. collateProtective effect of combined moxibustion and decoction therapy on Bleomycin-induced pulmonary fibrosis in rats under Nuclear Factor-κB/Transforming Growth Factor-β1/Smads signaling pathway;Cellular and Molecular Biology;2022-06-30